VFA
INFI

Virtus Fund Advisers’s Infinity Pharmaceuticals, Inc. INFI Stock Holding History

Virtus Fund Advisers’s Portfolio INFI Stock Details INFI Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2014
Q3 		– Sell
-4,142
Closed -$53K – 2067
2014
Q2 		$53K Buy
+4,142
New +$43.1K ﹤0.01% 1825

Other funds holding INFI

O
OrbiMed New York $5.05B AUM 125.28% 1-Year Est. Return
DM
Deerfield Management New York $8.48B AUM 99.04% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BB
BB Biotech Schaffhausen, Switzerland $3.98B AUM 15.47% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.14% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Point72 Asset Management
Point72 Asset Management Stamford, Connecticut $78.1B AUM 55.25% 1-Year Est. Return

Virtus Fund Advisers's INFI Position: Q3 2014 in Review

Virtus Fund Advisers sold out of Infinity Pharmaceuticals, Inc. (INFI) in Q3 2014, closing a stake of 4,142 shares — an estimated $53K sold.

Virtus Fund Advisers first reported a position in INFI in Q2 2014 and held it in 1 quarter. The position peaked at $53K in Q2 2014. 118 funds tracked by Wall St. Rank hold INFI as of Q3 2014.

  • Virtus Fund Advisers reported no remaining Infinity Pharmaceuticals, Inc. position as of Q3 2014 after selling out during the quarter.
  • Virtus Fund Advisers sold 4,142 Infinity Pharmaceuticals, Inc. shares in Q3 2014, an estimated $53K.
  • Virtus Fund Advisers first reported a position in Infinity Pharmaceuticals, Inc. in Q2 2014 and held it in 1 quarter.
  • Virtus Fund Advisers's Infinity Pharmaceuticals, Inc. position peaked at $53K in Q2 2014.
  • 118 funds tracked by Wall St. Rank held Infinity Pharmaceuticals, Inc. as of Q3 2014.

Based on Virtus Fund Advisers's 13F filing for Q3 2014, filed 31 Oct 2014.